Sigma-1 receptor agonist fluvoxamine for delirium in older adults

International Journal of Geriatric Psychiatry

Volumn 27, Issue 9, 2012, Pages 981-983

  Hashimoto, Kenji ^a   Furuse, Tsutomu ^b  

^a CHIBA UNIVERSITY   (Japan)

^b Nakano Memorial Hospital Hokkaido   (Japan)

Author keywords

Cognition; Delirium; Fluvoxamine; Sigma 1 receptor

Indexed keywords

CUTAMESINE; FLUVOXAMINE; NEUROLEPTIC AGENT; SIGMA 1 OPIATE RECEPTOR;

ACUTE STRESS; ALZHEIMER DISEASE; COGNITION; DELIRIUM; DRUG EFFICACY; DRUG INTOXICATION; DRUG MECHANISM; DRUG SAFETY; ENDOPLASMIC RETICULUM; EXTRAPYRAMIDAL SYMPTOM; GERIATRIC DISORDER; HEART ARRHYTHMIA; HUMAN; INFLAMMATION; MORTALITY; NEUROTRANSMISSION; NOTE; SEDATION; SIDE EFFECT;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DELIRIUM; FLUVOXAMINE; HUMANS; RECEPTORS, SIGMA; SEROTONIN UPTAKE INHIBITORS;

EID: 84861377368     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2809     Document Type: Note

References (6)

1. Fong TG, Tulebaev SR, Inouye SK,. 2009. Delirium in elderly adults: diagnosis, prevention and treatment. Nature Rev Neurol 5: 210-220.
2. Furuse T, Hashimoto K,. 2010a. Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease. Ann Gen Psychiatry 9: 6.
3. Furuse T, Hashimoto K,. 2010b. Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of 5 cases. Ann Gen Psychiatry 9: 18.
4. Furuse T, Hashimoto K,. 2010c. Sigma-1 receptor agonist fluvoxamine for postoperative delirium in older adults: report of three cases. Ann Gen Psychiatry 9: 28.
5. Hashimoto K,. 2009. Sigma-1 receptors and selective setoronin reuptake inhibitors: clinical implications of their relationship. Cent Nerv Syst Agents Med Chem 9: 197-204.
6. Hayashi T, Tsai SY, Mori T, Fujimoto M, Su TP,. 2011. Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders. Expert Opin Ther Targets 15: 557-577.